--

I have no quibbles with your overall analysis, George. Thank you. As you led by saying, our current markers are suboptimal. I hope new tests like these are better indicators, even as we better understand the genetics of the disease. I actually don't know what fraction of risk is thought attributible primarily to genetics. Do you have studies to show indicate that? I would guess it would have to be identical twin studies, out of Scandanavia. Thanks for stopping by and weighing in. Appreciate you.

Warm regards,

Michael

--

--

Michael Hunter, MD
Michael Hunter, MD

Written by Michael Hunter, MD

I have degrees from Harvard, Yale, and Penn. I am a radiation oncologist in the Seattle area. You may find me regularly posting at www.newcancerinfo.com

Responses (1)